The opening keynote presenters include Ingrid E. Akerblom, Ph.D., Executive Director, Discovery & Pre-Clinical IT, Merck Research Laboratories;
- Integration of internal & external data
- Integrating & accessing non-standard public data to drive R&D
- Workflow project
- Meeting the informatics needs to support biologics development
- Informatics for translational science
Participating organizations include: Abbott Labs, Accelrys Inc, Agilent Technologies, Allergan Inc., American Medical Association, Arizona State University, Astellas Pharma Inc., AstraZeneca Pharmaceuticals Inc., Atrium Research & Consulting, Ayasdi Inc., Biogen Idec Inc., BioTeam Inc., Boehringer-Ingelheim Pharma, Broad Institute, Carmot Therapeutics Inc., Celgene Signal Research, Certara, Charles River Labs Preclinical Services, ChemAxon Ltd Chemical Computing Group Inc., Collaborative Drug Discovery Inc., Complete Genomics Inc., Core Informatics, Covance Genomics Lab, DataDirect Networks Inc., Debiopharm SA, Distributed Bio LLC, Dolcera, Dotmatics Ltd Drexel University, Duke University, E Merge Tech Global Svcs Pvt Ltd, Eli Lilly & Co., Elsevier Inc., Ezose Sciences, F. Hoffmann La Roche Inc., Genentech Inc., Genomic Health Inc., Genoptix Inc., GGA Software Svcs LLC, Gilead Sciences Inc., GlaxoSmithKline, goBalto, IDBS, Indiana University, Ingenuity Systems Inc., Isilon Systems Inc., Johns Hopkins University, Johnson & Johnson Pharmaceutical R&D, LHASA Ltd., LIMSource, Linguamatics, Lockheed Martin, Oreal, MathWorks, Medical College of Wisconsin, MedImmune, Merck & Co Inc., Merck Serono Research, Michigan State University, Millennium The Takeda Oncology Co., Momenta Pharmaceuticals Inc., Nationwide Children’s Hospital, National Nanotechnology Center, NeoProteomics Inc., NextBio Inc., NIH NCI, Novartis Institutes for BioMedical Research Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corp., Novartis Vaccines & Diagnostics Inc., OncoMed Pharmaceuticals Inc., One World Health, Optibrium Ltd., Partners HealthCare System Inc., Pathwork Diagnostics, Pfizer Global R&D, Pfizer Global R&D Groton Labs, Pfizer Inc., PointCross Life Sciences, Real Time Genomics Inc., Reed Elsevier, RemedyMD, revelytix, Roche, Samsung Advanced Institute of Technology, sanofi aventis Grp, Simulations Plus Inc., SomaLogic Inc., Spry, St. Jude Children’s Research Hospital, Stanford University, SUNY Buffalo, Tessella Inc., Thomson Reuters, TNO Quality of Life, Tufts University , University of British Columbia, University of Miami, University of Utah, VA Medical Center Boston, Vanderbilt University, Vertex Pharmaceuticals Inc., and Wexford Press.
The Integrated R&D Informatics & Knowledge Management conference is one of the program offerings at CHI’s flagship event, the Molecular Medicine Tri-Conference (February 19-23). This international event features 2 partnering forums, 5 symposia, 18 short courses, and 12 core programs around 4 scientific channels: diagnostics, drug discovery & development, informatics, and cancer. Over 3000 attendees and 150+ sponsors & exhibitors will gather in shared networking functions and in the exhibit/poster hall.
To view the agenda and to register, please visit http://www.triconference.com/
Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at email@example.com.
About Cambridge Healthtech Institute (www.chicorporate.com)
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.